25P-NBOH
A synthetic psychedelic compound
25P-NBOH is a synthetic psychedelic compound that belongs to the N-benzylphenethylamine class. It is a derivative of the phenethylamine 2C-P and is closely related to other compounds in the 25-NBOH series, such as 25I-NBOH and 25C-NBOH.
Chemical Structure and Properties[edit | edit source]
25P-NBOH is chemically known as 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine. It features a phenethylamine core with a bromine atom at the 4-position and methoxy groups at the 2- and 5-positions of the phenyl ring. The N-benzyl group is substituted with a 2-methoxyphenyl group, which is characteristic of the NBOH series.
Pharmacology[edit | edit source]
25P-NBOH acts as a potent agonist at the 5-HT2A receptor, which is the primary target for classical psychedelics such as LSD and psilocybin. The activation of this receptor is responsible for the psychedelic effects experienced by users. The compound is known for its high affinity and selectivity for the 5-HT2A receptor, which contributes to its potent effects even at low doses.
Effects[edit | edit source]
The effects of 25P-NBOH are similar to those of other psychedelics, including altered perception of time and space, visual hallucinations, and changes in thought processes. Users may experience enhanced sensory perception, emotional shifts, and a sense of euphoria. The intensity and duration of effects can vary depending on the dose and route of administration.
Safety and Toxicity[edit | edit source]
As with many research chemicals, the safety profile of 25P-NBOH is not well-established. There is limited data on its toxicity, long-term effects, and potential for abuse. Users should exercise caution and be aware of the potential risks associated with its use. It is important to note that the legal status of 25P-NBOH may vary by country and region.
Legal Status[edit | edit source]
25P-NBOH is not specifically scheduled under the United Nations Convention on Psychotropic Substances, but it may be considered illegal in some jurisdictions under analogue laws. Researchers and users should verify the legal status of this compound in their respective countries.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
